Related Experiment Video
Updated: Jul 5, 2026

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function
Philippe Bertolino1, Rebecka Holmberg, Eva Reissmann
1Division of Molecular Neurobiology, Department of Neuroscience, Karolinska Institutet, S-17177 Stockholm, Sweden.
Abstract:
All major cell types in pancreatic islets express the transforming growth factor (TGF)-beta superfamily receptor ALK7, but the physiological function of this receptor has been unknown. Mutant mice lacking ALK7 showed normal pancreas organogenesis but developed an age-dependent syndrome involving progressive hyperinsulinemia, reduced insulin sensitivity, liver steatosis, impaired glucose tolerance, and islet enlargement. Hyperinsulinemia preceded the development of any other defect, indicating that this may be one primary consequence of the lack of ALK7. In agreement with this, mutant islets showed enhanced insulin secretion under sustained glucose stimulation, indicating that ALK7 negatively regulates glucose-stimulated insulin release in beta-cells. Glucose increased expression of ALK7 and its ligand activin B in islets, but decreased that of activin A, which does not signal through ALK7. The two activins had opposite effects on Ca(2+) signaling in islet cells, with activin A increasing, but activin B decreasing, glucose-stimulated Ca(2+) influx. On its own, activin B had no effect on WT cells, but stimulated Ca(2+) influx in cells lacking ALK7. In accordance with this, mutant mice lacking activin B showed hyperinsulinemia comparable with that of Alk7(-/-) mice, but double mutants showed no additive effects, suggesting that ALK7 and activin B function in a common pathway to regulate insulin secretion. These findings uncover an unexpected antagonism between activins A and B in the control of Ca(2+) signaling in beta-cells. We propose that ALK7 plays an important role in regulating the functional plasticity of pancreatic islets, negatively affecting beta-cell function by mediating the effects of activin B on Ca(2+) signaling.
Insights
Mice lacking the ALK7 receptor developed hyperinsulinemia and impaired glucose tolerance, indicating ALK7 negatively regulates insulin secretion. Activin B signaling through ALK7 is crucial for controlling pancreatic islet function.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Signaling
Background:
- The transforming growth factor (TGF)-beta superfamily receptor ALK7 is expressed in pancreatic islets, but its physiological role remains unclear.
- Understanding ALK7's function is crucial for deciphering pancreatic islet regulation and potential therapeutic targets for metabolic disorders.
Purpose of the Study:
- To investigate the physiological function of the ALK7 receptor in pancreatic islets.
- To elucidate the role of ALK7 in regulating insulin secretion and glucose homeostasis.
Main Methods:
- Utilized mutant mice lacking the ALK7 receptor (Alk7-/-) to study age-dependent metabolic phenotypes.
- Analyzed insulin secretion, glucose tolerance, liver steatosis, and islet morphology in wild-type and mutant mice.
- Investigated the effects of activins A and B on calcium (Ca2+) signaling in islet cells.
Main Results:
- Alk7-/- mice exhibited progressive hyperinsulinemia, reduced insulin sensitivity, liver steatosis, impaired glucose tolerance, and islet enlargement.
- Mutant islets demonstrated enhanced insulin secretion under sustained glucose stimulation, suggesting ALK7 negatively regulates this process.
- Activin B, but not activin A, signaling through ALK7 was found to decrease glucose-stimulated Ca2+ influx in beta-cells, while activin A increased it, revealing an antagonism.
Conclusions:
- ALK7 negatively regulates glucose-stimulated insulin secretion in pancreatic beta-cells, primarily by mediating the inhibitory effects of activin B on Ca2+ signaling.
- The ALK7-activin B pathway plays a significant role in maintaining functional plasticity and homeostasis within pancreatic islets.
- Dysregulation of the ALK7-activin B pathway may contribute to the pathogenesis of metabolic disorders characterized by hyperinsulinemia and impaired glucose tolerance.
Related Concept Videos
Cell Specific Gene Expression
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Feedback Loops
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways

